3 Year Returns
19.20%
NAV (₹)
17.0649
1 Day NAV Change
-1.53%
No chart data available for this period.
Fund Details
| Min. SIP Amount | ₹ 1000 |
| Min. Lumpsum Amount | ₹ 5000 |
| AUM | ₹ 391.06 Cr |
| Expense Ratio | 3.01% |
| Lock-in Period | No Lock-in Period |
| Inception Date | 17 Jul 2023 |
| Fund Age | 3 Yrs |
Exit Load
For redemptions / switch outs (including SIP/STP) within 15 days from the date of allotment of units, irrepective of the amount of investment: 1% Nil - For redemption / switch outs after 15 days from the date of allotment.
Fund’s Investment Objective
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Calculate Your Mutual Fund Returns
Returns Estimator
Estimation is based on the past performance
Expected Rate of Return
The value of your investment after 5 Years will be
₹4,12,432
Invested Amount
₹3,00,000
Est. Returns
₹1,12,432
Scheme’s Historical Return
1 Month Return2.90%
3 Month Return13.25%
6 Month Return22.40%
1 Year Return12.45%
3 Year Return19.20%
Asset Allocation
AUM
₹1,33,309.00 Cr
Cash Holdings
21.45%
Equity
70.84%
Cash
21.45%
Debt
1.71%
Other
6%
Sector Holdings
Last Updated: 30 Jun 2026| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Pharmaceuticals | 56.08% | ₹ 219.305 | |
| Healthcare | 15.47% | ₹ 60.495 | |
| Telecom Equipment & Infra Services | 15.15% | ₹ 59.262 | |
| FMCG | 13.30% | ₹ 51.996 |
Stock Holdings
Last Updated: 30 Jun 2026| Name | Allocation | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|---|
| TREPS | 21.73% | ₹ 84.978 | Debt Others | |
| HFCL | 10.76% | ₹ 42.085 | Telecom Equipment & Infra Services | |
| Zydus Wellness | 9.44% | ₹ 36.925 | FMCG | |
| Aster DM Health. | 8.96% | ₹ 35.039 | Healthcare | |
| Concord Biotech | 8.84% | ₹ 34.558 | Pharmaceuticals | |
| Glenmark Pharma. | 8.70% | ₹ 34.037 | Debt Others | |
| SMS Pharma. | 8.15% | ₹ 31.879 | Pharmaceuticals | |
| Alivus Life | 7.28% | ₹ 28.484 | Pharmaceuticals | |
| Max Healthcare | 5.80% | ₹ 22.666 | Debt Others | |
| Divi's Lab. | 5.74% | ₹ 22.454 | Debt Others |
Fund Manager Details
He has total work experience of 18 years including 13 years of experience in the financial market. He specializes in identifying crucial inflexion points in securities. PGDBA(Fin.), M.com and CerTM (Treasury & Forex Risk)
He started his career in equity research in 2011, picking up the (U.S. based) CFA charter in 2015 and MBA from the chinese university of hong kong in 2017. He won the thomson reuters starmine award for best stock picker in the IT sector in 2014 and is a lifetime member of the Beta Gamma Sigma honour society. CFA, MBA
Sandeep Tandon is the founder of the quant group and has 20 years of experience in the financial services industry. Sandeep's previous stints include a key role in setting up the equity derivatives desk at ICICI Securities as vice president. He started his career with the Economic Times Research Bureau, a research wing of the leading financial daily of India, The Economic Times. He later joined IDBI Asset Management (now Principal Asset Management), and was part of the core team that initialized asset management, playing a key role in devising, conceptualizing and marketing one of India's most successful mutual schemes: IDBI I-NITS 95. MBA
Varun joined quant in May 2021 as an analyst. Coming from a Chartered accountancy background, he has diverse set of knowledge in areas of finance & tax. He has experience in tracking Indian equities across sectors and is a true believer of research backed investment process. Chartered Accountant
Sameer has over two decades of experience in Indian equities and derivatives dealing. Prior to joining quant MF, Sameer was Sr. Sales Trader at Investec Capital covering equity and derivatives trading for domestic and foreign institutional clients. He has also worked for over 16 years at Kotak Securities as a Sales Trader. Bachelor of Computer Science, MBA from IME Pune
Ayusha has been working at quant Mutual Fund as a Research Analyst for the past 15 months, specializing in investment research, economics and strategy. Her strong analytical foundation and quantitative expertise have significantly contributed to the fund's in-depth economic and strategic investment analysis. She has also led engagement initiatives with portfolio companies to inform investment decisions and has effectively utilized data and AI to enhance processes. CFA - Level III, BSc (Hons) in Economics - University of Warwick, MSc in Behavioural & Experimental Economics - University of East Anglia
Yug Tibrewal is a CFA charter holder with over seven years of diverse experience in financial markets. At quant Mutual Fund, he specializes in liquidity analytics, fundamental research, and portfolio risk mitigation, while overseeing trade execution and analytics. Bachelor of Management studies (B.M.S) and CFA charter holder
Risk-O-Meter
Very High Risk
Investors understand that their principal will be at Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
Quant Mutual Fund
Funds Managed
29
Assets Managed
₹ 95,314.40 Cr
Contact Details
Registered Address
6th Floor, Sea Breeze Building,Appasaheb Marathe Marg,Prabhadevi Mumbai - 400025
Managing Director
Nishith Mehta
Chief Executive Officer
Mr. Sandeep Tandon
Compliance Officer
Ms. Usha Lakshmi Raman
Mutual Funds Calculators
Explore Mutual Funds by Types
Open NFOs
Explore Popular AMCs
SBI Mutual FundICICI Prudential Mutual FundHDFC Mutual FundNippon India Mutual FundKotak Mahindra Mutual FundAditya Birla Sun Life Mutual FundUTI Mutual FundAxis Mutual FundDSP Mutual FundMirae Asset Mutual FundTata Mutual FundBandhan Mutual FundEdelweiss Mutual FundPPFAS Mutual FundMotilal Oswal Mutual FundInvesco Mutual FundHSBC Mutual FundFranklin Templeton Mutual FundCanara Robeco Mutual FundQuant Mutual FundSundaram Mutual FundBaroda BNP Paribas Mutual FundLIC Mutual FundWhiteOak Capital Mutual Fund
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
You can withdraw your investment from Quant Healthcare Fund - Regular (G) through your mutual fund app, AMC website, or demat or stock broker online account at the applicable NAV.
The minimum investment for Quant Healthcare Fund - Regular (G) is ₹ 5000 for Lumpsum and ₹ 1000 for SIP. You can open a demat account or login to the existing stock broker online account to get started.
Quant Healthcare Fund - Regular (G) has a lock-in period of No Lock-in Period. Schemes with a lock-in restrict withdrawals or redemptions for that duration, while schemes with no lock-in allow you to redeem anytime.
The average annualized return of Quant Healthcare Fund - Regular (G) over the past three years is 19.20%.
The current NAV of Quant Healthcare Fund - Regular (G) is 17.0649.
The Expense ratio of Quant Healthcare Fund - Regular (G) is 3.01%. It is an annual charge for running the mutual fund. You can find the same on the factsheet and the Asset Management Companies website.
The latest AUM of the Quant Healthcare Fund - Regular (G) fund is ₹ 391.06 Cr. It represents the total assets held and managed by the fund.
The exit load for Quant Healthcare Fund - Regular (G) is For redemptions / switch outs (including SIP/STP) within 15 days from the date of allotment of units, irrepective of the amount of investment: 1% Nil - For redemption / switch outs after 15 days from the date of allotment..
The fund managers of the Quant Healthcare Fund - Regular (G) are Sanjeev Sharma, Ankit A. Pande, Sandeep Tandon, Varun Pattani, Sameer Kate, Ayusha Kumbhat, Yug Tibrewal. However, with management's discretion, the fund manager could also change during the tenure.
Quant Healthcare Fund - Regular (G) was launched on 17 Jul 2023. Since then, the fund has formed an NAV (Net Asset Value) of 17.0649.
Download the AR Invest App
- 5000+ Schemes
- Personalized Solutions
- Expert Insights
